Page 391 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 391

CHAPTER 21  Introduction to the Pharmacology of CNS Drugs         377


                    TABLE 21–2  Summary of neurotransmitter pharmacology in the central nervous system. (Continued)

                                                            Receptor Subtypes
                     Transmitter       Anatomy              and Preferred Agonists  Receptor Antagonists  Mechanisms
                                                                                                                     2+
                     Opioid peptides   Cell bodies at all levels;   Mu: bendorphin  Naloxone      Inhibitory (presynaptic): ↓ Ca
                                       long and short connections                                 conductance, ↓ cAMP
                                                                                                                     +
                                                            Delta: enkephalin  Naloxone           Inhibitory (postsynaptic): ↑ K
                                                                                                  conductance, ↓ cAMP
                                                                                                                     +
                                                            Kappa: dynorphin,    Naloxone         Inhibitory (postsynaptic): ↑ K
                                                            salvinorin A                          conductance, ↓ cAMP
                     Orexins           Cell bodies in hypothala-  OX 1 : orexin A  Suvorexant     Excitatory, glutamate co-release
                                       mus; project widely
                                                            OX 2 : orexins A and B  Suvorexant
                                                                                                            +
                     Tachykinins       Primary sensory neurons,   NK1: substance P   Aprepitant   Excitatory: ↓ K  conductance,
                                       cell bodies at all levels; long   methylester              ↑ IP 3 , DAG
                                       and short connections
                                                                                                            +
                                                            NK2: neurokinin A  Saredutant         Excitatory: ↓ K  conductance,
                                                                                                  ↑ IP 3 , DAG
                                                                                                            +
                                                            NK3: neurokinin B  Osanetant          Excitatory: ↓ K  conductance,
                                                                                                  ↑ IP 3 , DAG
                                                                                                                     2+
                     Endocannabinoids  Widely distributed   CB1: anandamide,   Rimonabant         Inhibitory (presynaptic): ↓ Ca
                                                            2-arachidonyglycerol                  conductance, ↓ cAMP
                    Note: Many other central transmitters have been identified (see text).
                    ACET, (S)-1-(2-amino-2-carboxyethyl)-3-(2-carboxy-5-phenylthiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione; ACPD,  trans-1-amino-cyclopentyl-1,3-dicarboxylate; AMPA,
                    DL-α-amino-3-hydroxy-5-methylisoxazole-4-propionate; cAMP, cyclic adenosine monophosphate; DAG, diacylglycerol; IP 3 , inositol trisphosphate; LSD, lysergic acid diethylamide;
                    MCPG, α-methyl-4-carboxyphenylglycine; NBQX, 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline.









                                                                                A
                                                                         Glutamine
                                                                            Glutaminase
                                              C                          Glutamate
                                                                                 VGLUT
                                                  Glutamine

                                                      Glutamine
                                                      synthetase
                                                  Glutamate




                                                                         mGluR  AMPAR  NMDAR
                                                                                   B







                    FIGURE 21–7  Schematic diagram of a glutamate synapse. Glutamine is imported into the glutamatergic neuron (A) and converted into
                    glutamate by glutaminase. The glutamate is then concentrated in vesicles by the vesicular glutamate transporter (VGLUT). Upon release into
                    the synapse, glutamate can interact with AMPA and NMDA ionotropic receptor channels (AMPAR, NMDAR) and with metabotropic receptors
                    (mGluR) on the postsynaptic cell (B). Synaptic transmission is terminated by active transport of the glutamate into a neighboring glial cell (C)
                    by a glutamate transporter. It is converted into glutamine by glutamine synthetase and transported back into the glutamatergic axon terminal.
   386   387   388   389   390   391   392   393   394   395   396